|
Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or treatment with a real dr.. We aren't doctors. Always consult your mD on Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer Clinical research trials and Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer medical trials occur in many of places across the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectiveness of new does drugs. The role of the studies / undertakings is to figure out certain human healthcare questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to locate treatments for all forms of circumstances, including Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer. Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer Clinical Trials and other clinical trials permit volunteers to get medical treatment options before they are available to the masses. Most times the human subjects acquire treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer clinical trial. Participants oftentimes recieve the finest healthcare available for their Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer condition. Dangers are a reality, nonetheless, and might include extra or frequent physician calls, health hazards (potentially life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "D" Clinical Trials Conditions > Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer  Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer
Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer
For Condition: childhood thorax/respiratory cancer,Quality of Life,stage 2 non-small cell lung cancer,stage 1 non-small cell lung cancer,limited stage small cell lung cancer
Status: No longer recruiting
Sponsor(s): Royal Marsden NHS Trust ,
Synopsis: RATIONALE: Diagnostic procedures and treatment-planning systems may affect outcome in patients suspected of having lung cancer. PURPOSE: Randomized diagnostic trial to compare the effectiveness of two types of diagnostic and treatment-planning systems in patients who are suspected of having lung cancer.
Details: OBJECTIVES: I. Compare the survival rate of patients with suspected lung cancer when diagnosed and managed using the conventional locally based approach versus a new centralized system using a 2 stop diagnosis. II. Compare the resection rate in both diagnostic arms. III. Assess the quality of service given in both diagnostic arms. PROTOCOL OUTLINE: This is a randomized study. Patients present to a general practitioner where they are referred to the local chest clinic. Patients are seen by the chest physician and, if deemed eligible, are randomized between 2 diagnostic arms. Arm I (Conventional Locally Based Diagnosis): Patients undergo bronchoscopy and CT scan as appropriate, and then are discussed or referred by individual chest physicians, as is the current practice. The optimal period for diagnosis and discussion of management plans is 6 weeks. Arm II (Centralized 2 Stop Diagnosis): Patients undergo CT scan the following Monday morning. The consultant radiologist advises the most appropriate diagnostic test (e.g., bronchoscopy or percutaneous needle biopsy) to be done that same Monday. A tissue diagnosis is available Thursday morning for the multidisciplinary meeting attended by the chest physician, medical and clinical oncologists, and a surgeon, and the patient treatment plan is decided. Quality of life is assessed at baseline and at 6 weeks. Patients are followed for 2 years. PROJECTED ACCRUAL: A total of 252-315 patients will be accrued for this study within 2 years.
Eligibility:
Study Type: Interventional, Diagnostic
Minimum Age/Maximum Age: /
Genders:
Protocol Entry Criteria: PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- - Possible diagnosis of lung cancer - Fit enough for bronchoscopy and CT scan --Prior/Concurrent Therapy-- - Not specified --Patient Characteristics-- - Age: Not specified - Performance status: Not specified - Life expectancy: Not specified - Hematopoietic: Not specified - Hepatic: Not specified - Renal: Not specified
Total Enrollment:
Location and Contact Information:
Overall Study Official:
MaryO'Brien, Study Chair, Royal Marsden NHS Trust
Royal Marsden Hospital
Sutton, England, SM2 5PT
United Kingdom
Additional Information:
Study ID Numbers: CDR0000067676; RMNHS-PATHWAY,EU-99039
Study Start Date: October 1998
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00005071
Other Stage 2 Non-Small Cell Lung Cancer Studies:
1. Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
2. Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer
3. Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma
4. Phase I/II Study of Lepirudin in Patients with Recurrent or Extensive Stage Small Cell Lung Cancer
Related Studies:
Other stage 2 non-small cell lung cancer Clinical Trials
Other England Clinical Trials
Other Sutton Clinical Trials
Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer
|
|
|
|
|
|
|
|
